Hot PD-(L)1xVEGF Space to Continue Delivering Key Data In '25; TIL Upped to Buy_老虎社区_美港股上老虎

Hot PD-(L)1xVEGF Space to Continue Delivering Key Data In '25; TIL Upped to Buy

宜明昂科
03-17

2024 was a banner year for PD-(L)1xVEGF class and we expect the hype

to continue in 2025 with two key catalysts on the horizon: HARMONi-2 OS

Data (YE25/Early26) and first global Ph3 data (Mid-25). We anticipate positive

results from both, and continued excitement to attract more deals in the space.

We see sig upside for TIL as its SYN2510 is the 3rd US asset w/ global trial

planned in 2025 and stock is currently trading ~cash. Upgrade to Buy w/ $52

PT.

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":414482148393016,"tweetId":"414482148393016","gmtCreate":1742202409139,"gmtModify":1742202417712,"author":{"id":4160806183340380,"idStr":"4160806183340380","authorId":4160806183340380,"authorIdStr":"4160806183340380","name":"宜明昂科","avatar":"https://static.tigerbbs.com/fc8b5d5a10d5195cf4f8e2800e49fee1","vip":5,"userType":5,"introduction":"以科研为导向的生物技术公司，致力于开发肿瘤免疫疗法。","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":280,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/166d3b1cfae163291bdad4f88b95c677","width":"1700","height":"2200"}],"coverImages":[{"img":"https://static.tigerbbs.com/166d3b1cfae163291bdad4f88b95c677","width":"1700","height":"2200"}],"title":"Hot PD-(L)1xVEGF Space to Continue Delivering Key Data In '25; TIL Upped to Buy","html":"<html><head></head><body>\n<img src=\"https://static.tigerbbs.com/166d3b1cfae163291bdad4f88b95c677\" tg-width=\"1700\" tg-height=\"2200\">\n2024 was a banner year for PD-(L)1xVEGF class and we expect the hype\nto continue in 2025 with two key catalysts on the horizon: HARMONi-2 OS\nData (YE25/Early26) and first global Ph3 data (Mid-25). We anticipate positive\nresults from both, and continued excitement to attract more deals in the space.\nWe see sig upside for TIL as its SYN2510 is the 3rd US asset w/ global trial\nplanned in 2025 and stock is currently trading ~cash. Upgrade to Buy w/ $52\nPT.</body></html>","htmlText":"<html><head></head><body>\n<img src=\"https://static.tigerbbs.com/166d3b1cfae163291bdad4f88b95c677\" tg-width=\"1700\" tg-height=\"2200\">\n2024 was a banner year for PD-(L)1xVEGF class and we expect the hype\nto continue in 2025 with two key catalysts on the horizon: HARMONi-2 OS\nData (YE25/Early26) and first global Ph3 data (Mid-25). We anticipate positive\nresults from both, and continued excitement to attract more deals in the space.\nWe see sig upside for TIL as its SYN2510 is the 3rd US asset w/ global trial\nplanned in 2025 and stock is currently trading ~cash. Upgrade to Buy w/ $52\nPT.</body></html>","text":"2024 was a banner year for PD-(L)1xVEGF class and we expect the hype to continue in 2025 with two key catalysts on the horizon: HARMONi-2 OS Data (YE25/Early26) and first global Ph3 data (Mid-25). We anticipate positive results from both, and continued excitement to attract more deals in the space. We see sig upside for TIL as its SYN2510 is the 3rd US asset w/ global trial planned in 2025 and stock is currently trading ~cash. Upgrade to Buy w/ $52 PT.","highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/414482148393016","repostId":0,"isVote":1,"tweetType":1,"viewCount":12075,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["01541","PD","L","TIL"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":375,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}